Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Aim to generate a one billion cell dataset to fuel rapid progress in AI model development in biology.
February 6, 2025
By: Charlie Sternberg
The Chan Zuckerberg Initiative (CZI), in collaboration with partners 10x Genomics, Ultima Genomics, and a group of leading researchers, has launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in biology.
Once completed, this single-cell data set will bring critical new data and resolution to multiple domains of biology that need comprehensive resources such as mapping genetic perturbations across diverse cell types and tissues. Critically, the scale and cohesion of the data made possible by current and future contributions to the Billion Cells Project will deliver the volume of data with greater consistency than past efforts to better enable researchers to train AI models and make transformative discoveries across precision medicine and functional genomics.
“CZI’s Billion Cells Project illustrates the power of collaboration to make previously unfathomable amounts of single-cell data available for researchers, which will help clarify our understanding of the fundamental biology underpinning human health and disease while supercharging efforts at the intersection of AI and biology,” said Jonah Cool, Cell Science Senior Science Program Officer at CZI. “Biology not only needs more data – the field needs more data faster and in interoperable formats to support AI models that address specific problems, and this project represents a unique approach to scaling and standardizing scientific outputs for AI and more.”
Data generated from the Billion Cells Project will be used to train new virtual cell models using CZI’s computing system to derive greater insight into the vast dataset. As part of its commitment to open science to accelerate research and make science more inclusive, CZI plans to make the results from this initiative open-source and freely available to help scientists around the world make new discoveries about human biology.
“This project will provide a necessary scale of data to understand the functional effects of human genetic variants and characterize the genetic drivers of human disease,” said Alexander Marson, Director of the Gladstone-UCSF Institute of Genomic Immunology and collaborator. “Ultimately, the Billion Cells Project will also be a functional roadmap to guide drug development, identifying targets to restore diseased cells to health.”
The collaboration will use 10x Genomics’ Chromium GEM-X technology for single-cell analysis, while sequencing will be performed on the UG 100, an ultra-high throughput next-generation sequencing (NGS) platform developed by Ultima Genomics.
As the Billion Cells Project progresses, CZI anticipates forming additional partnerships with industry and academia to ensure the timely delivery of its goals.
Read about the role of artificial intelligence in drug discovery.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !